Literature DB >> 29992829

Anticarcinogenic effect of indole-3-carbinol (I3C) on human hepatocellular carcinoma SNU449 cells.

C M Lee1, S-H Park2, M J Nam1.   

Abstract

Many cruciferous vegetables, including cabbage, contain indole-3-carbinol (I3C), which is a known anticarcinogen. However, the anticarcinogenic effects of I3C on liver cancer have not been investigated. Therefore, this study was conducted to evaluate the anticarcinogenic effects of I3C in human hepatocellular carcinoma (HCC) SNU449 cells. The results of MTT and WST-1 assays indicated that treatment of SNU449 cells with I3C decreased viability in dose- and time-dependent manners, while colony formation assays indicated that I3C also inhibited proliferation of SNU449 cells. Moreover, fluorescence-activated cell sorter analysis showed that I3C induced apoptosis in SNU449 cells in dose- and time-dependent manners. Furthermore, terminal deoxynucleotidyl transferase deoxyuridine triphosphate nick-end labeling revealed that I3C induced DNA fragmentation in SNU449 cells in a time-dependent manner, while Western blotting showed that apoptotic proteins such as p53, cleaved PARP, caspase-3, and caspase-7 were activated in SNU449 cells following treatment with I3C. Finally, reactive oxygen species-related protein peroxiredoxin-1 and thioredoxin-1 expression decreased in I3C-treated SNU449 cells. The aim of our study is to investigate the unknown mechanisms responsible for the apoptotic effects of I3C on human HCC SNU449 cells, and the results suggest that I3C may be useful for the prevention and treatment of liver cancer.

Entities:  

Keywords:  DNA fragmentation; Indole-3-carbinol; apoptosis; liver cancer

Mesh:

Substances:

Year:  2018        PMID: 29992829     DOI: 10.1177/0960327118785235

Source DB:  PubMed          Journal:  Hum Exp Toxicol        ISSN: 0960-3271            Impact factor:   2.903


  3 in total

1.  LCT-3d Induces Oxidative Stress-Mediated Apoptosis by Upregulating Death Receptor 5 in Gastric Cancer Cells.

Authors:  Menglin Wang; Xinxin Wu; Lu Yu; Zi-Yun Hu; Xiaobo Li; Xia Meng; Chun-Tao Lv; Gi-Young Kim; Yung Hyun Choi; Zhengya Wang; Hai-Wei Xu; Cheng-Yun Jin
Journal:  Front Oncol       Date:  2021-04-16       Impact factor: 6.244

Review 2.  Targeting AhR as a Novel Therapeutic Modality against Inflammatory Diseases.

Authors:  Alkeiver S Cannon; Prakash S Nagarkatti; Mitzi Nagarkatti
Journal:  Int J Mol Sci       Date:  2021-12-28       Impact factor: 5.923

Review 3.  The Potential of Phytochemicals in Oral Cancer Prevention and Therapy: A Review of the Evidence.

Authors:  Tzu-Ying Lee; Yu-Hsin Tseng
Journal:  Biomolecules       Date:  2020-08-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.